CSBR:NASDAQ
Champions Oncology Inc
US$4.70
arrow_upward
+1.18%(+0.055) 1D
ኖቬም 13, 4:00:00 ከሰዓት ጂ ኤም ቲ-5 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for CSBR...
Open
US$4.57
High
US$4.70
Low
US$4.52
Mkt. cap
65.49 ሚ
Avg. vol.
8.16 ሺ
Volume
3.02 ሺ
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
Open
US$4.57
High
US$4.70
Low
US$4.52
Mkt. cap
65.49 ሚ
Avg. vol.
8.16 ሺ
Volume
3.02 ሺ
52-wk high
US$8.31
52-wk low
US$4.52
EPS
-US$0.08
Beta
0.47
Shares outstanding
13.92 ሚ
No. of employees
217
News stories
From web sources and news partners
Bloomberg.com
·
ከ1 ሰዓት በፊት
SpaceX’s S&P 500 Bid Gets New Life as Musk Pitches Tesla Merger
The Motley Fool
·
ከ2 ሰዓቶች በፊት
Opinion: Buy This Growth Stock to Beat the S&P 500 in 2027
Trefis
·
ከ7 ሰዓቶች በፊት
S&P 500 Movers | Winners: CHTR, STE, GPN | Losers: AMD, DELL, CSCO
Traders Union
·
ከ2 ሰዓቶች በፊት
Gold volatility surpasses S&P 500 by 2.1 times, Mike McGlone notes
Profile
Champions Oncology is an American technology company that develops mouse avatars. Called TumorGrafts, they are used to test a panel of chemotherapy regimens, targeted therapies and monoclonal antibodies to identify potential therapeutic options for cancer patients. The company was founded in 2007 by David Sidransky, M.D., a Johns Hopkins University oncologist. Wikipedia
About Champions Oncology Inc
CEO-
Employees217
Founded2007
HeadquartersHackensack, ኒው ጄርዚ, ዩናይትድ ስቴትስ
SectorHealth Care
Industry-
Websitechampionsoncology.com